Stay Informed on Corporate Sustainability

Author: Archie Villaflores

Ireland’s National Clinical Trials Oversight Group published a 20-recommendation reform roadmap in November 2025. The report positions Ireland to close the gap with EU peers and attract more pharmaceutical sponsors to Irish research centres.

Author: Archie Villaflores

Throwing it back to the Pharma Industry Awards 2025, LEP Biomedical Ltd claimed the Best Use of Technology Award for a pioneering application of 3D drug printing that delivered bespoke ocular drug delivery solutions with controllable mechanical properties and precision-managed drug release across multiple parameters. The win set a compelling benchmark for technology-driven pharmaceutical innovation in Ireland, raising the standard of real-world clinical impact and formulation ingenuity that entrants will look to match when the 2026 awards cycle opens.

Author: Archie Villaflores

US pharmaceutical giant AbbVie has entered a licensing deal with China's Haisco Pharmaceutical Group worth up to $715 million, marking the company's first move into new pain medicines as competition in the non-opioid pain space intensifies.

Author: Archie Villaflores

Danish pharmaceutical giant Novo Nordisk has announced a strategic partnership with US-based OpenAI to embed artificial intelligence across its entire global operations, targeting full integration by the end of 2026 to accelerate drug discovery and manufacturing efficiency.

Author: Archie Villaflores

UK-based Alliance Pharmaceuticals has appointed global marketing and technology firm DEPT® as its end-to-end digital partner across the UK and Europe, covering creative, retail media management, and brand and performance media for its healthcare portfolio.

Author: Archie Villaflores

United Drug Wholesale has rebranded its Ostomy and Urology Care business unit as UroStomaCare, reinforcing its position as Ireland's leading provider of stoma and continence care products and services for pharmacy professionals and patients across Ireland.

Author: Archie Villaflores

IBSA UK&I, the UK subsidiary of Swiss pharmaceutical company IBSA, has assumed direct commercial and distribution responsibility for bladder therapy ialuril® across the UK and Ireland

Author: Archie Villaflores

Ireland’s biopharma sector grew pharmaceutical exports 29% in 2024 while cutting electricity-related carbon dioxide emissions by 30.5%. BioPharmaChem Ireland’s Responsible Care Report 2026 proves that high-value manufacturing and environmental stewardship can advance together.

Author: Archie Villaflores

Casting back to the Pharma Industry Awards 2025, Bristol Myers Squibb Ireland claimed last year the Communications Award for a recruitment campaign that put employees at the centre of the narrative, delivering a message of authenticity and creativity that resonated deeply with its target audience and produced measurable results. The win set a new standard for pharmaceutical communications in Ireland, demonstrating the level of strategic clarity, creative conviction, and evidenced impact that entrants will look to match on the 2026 awards cycle.

Author: Archie Villaflores

Canadian biopharmaceutical company Avicanna has appointed Ozgur Kilic to its board of directors, following the resignation of John McVicar, as the cannabinoid-focused firm targets further expansion in the United States and international markets.